Boston Partners
OVID icon

Boston Partners’s Ovid Therapeutics OVID Stock Holding History

Boston Partners’s Portfolio OVID Stock Details OVID Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-77,003
Closed -$199K – 732
2023
Q1 		$199K Hold
77,003
– – ﹤0.01% 674
2022
Q4 		$143K Hold
77,003
– – ﹤0.01% 678
2022
Q3 		$142K Buy
77,003
+847
+1% +$1.77K ﹤0.01% 686
2022
Q2 		$164K Sell
76,156
-8,105
-10% -$19.6K ﹤0.01% 676
2022
Q1 		$265K Hold
84,261
– – ﹤0.01% 663
2021
Q4 		$270K Buy
+84,261
New +$289K ﹤0.01% 650

Other funds holding OVID

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
TA
TLS Advisors Miami, Florida $42.1M AUM 25.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return